IRVINE, Calif., Aug. 29, 2023 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company’s management team will participate at the upcoming healthcare investor conferences. Citi BioPharma ConferenceDate: Wednesday, September 6 – Thursday, September… Continue reading Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
